|
63
|
241
|
4quxG |
Ycp beta5-a49t-mutant |
|
59
|
226
|
4r02H |
Ycp in complex with bsc4999 (alpha-keto phenylamide) |
|
65
|
250
|
4qw0A |
Ycp beta5-a49t-a50v-double mutant in complex with bortezomib |
|
69
|
242
|
4quxD |
Ycp beta5-a49t-mutant |
|
69
|
250
|
4qz3A |
Ycp beta5-a49v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
56
|
204
|
4qv5I |
Ycp beta5-m45i mutant |
|
65
|
201
|
4r3oL |
Human constitutive 20s proteasome |
|
70
|
243
|
4qwlF |
Ycp beta5-a50v mutant in complex with carfilzomib |
|
65
|
250
|
4qvmA |
Ycp beta5-m45a mutant in complex with bortezomib |
|
67
|
242
|
4qz4D |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
69
|
233
|
4qwlM |
Ycp beta5-a50v mutant in complex with carfilzomib |
|
68
|
233
|
4qvnM |
Ycp beta5-m45v mutant in complex with bortezomib |
|
64
|
242
|
4qlvD |
Ycp in complex with tripeptidic epoxyketone inhibitor 17 |
|
68
|
250
|
4qzwA |
Ycp beta5-c52f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
66
|
242
|
4qw7D |
Ycp beta5-m45t mutant in complex with carfilzomib |
|
67
|
250
|
4qvyA |
Ycp beta5-a49t-mutant in complex with bortezomib |
|
63
|
250
|
4qlvA |
Ycp in complex with tripeptidic epoxyketone inhibitor 17 |
|
57
|
222
|
4qxjH |
Ycp beta5-m45a mutant in complex with the epoxyketone inhibitor onx 0914 |
|
63
|
195
|
4qvyJ |
Ycp beta5-a49t-mutant in complex with bortezomib |
|
71
|
240
|
4qv4C |
Ycp beta5-m45t mutant |
|
68
|
240
|
4qwiC |
Ycp beta5-a49s-mutant in complex with carfilzomib |
|
57
|
204
|
4qz2I |
Ycp beta5-m45i mutant in complex with the epoxyketone inhibitor onx 0914 |
|
65
|
244
|
4qwkB |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
70
|
243
|
4qvwF |
Ycp beta5-a49s-mutant in complex with bortezomib |
|
70
|
242
|
4qv3D |
Ycp beta5-m45v mutant |
|
72
|
244
|
4qv8B |
Ycp beta5-c52f mutant |
|
71
|
212
|
4qluK |
Ycp in complex with tripeptidic epoxyketone inhibitor 9 |
|
70
|
243
|
4qwuF |
Ycp beta5-c52f mutant in complex with bortezomib |
|
63
|
195
|
4qw3J |
Ycp beta5-c63f mutant in complex with bortezomib |
|
70
|
243
|
4qvmF |
Ycp beta5-m45a mutant in complex with bortezomib |
|
63
|
241
|
4r18G |
Ligand-induced lys33-thr1 crosslinking at subunit beta5 of the yeast 20s proteasome |
|
67
|
240
|
4qwfC |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
70
|
242
|
4r17D |
Ligand-induced aziridine-formation at subunit beta5 of the yeast 20s proteasome |
|
69
|
244
|
4qz0B |
Ycp beta5-m45v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
69
|
242
|
4qv7D |
Ycp beta5-a50v mutant |
|
63
|
241
|
4qw4G |
Ycp in complex with carfilzomib |
|
69
|
212
|
4qv7K |
Ycp beta5-a50v mutant |
|
63
|
241
|
4qv7G |
Ycp beta5-a50v mutant |
|
57
|
222
|
4qwkL |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
71
|
243
|
4qwfF |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
61
|
195
|
4qv8J |
Ycp beta5-c52f mutant |
|
70
|
212
|
4qlsK |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
62
|
195
|
4r00J |
Ycp beta5-c52f mutant in complex with omuralide |
|
72
|
240
|
4qw1C |
Ycp beta5-a50v mutant in complex with bortezomib |
|
57
|
204
|
4quyI |
Ycp beta5-a49s-mutant |
|
65
|
240
|
4r18C |
Ligand-induced lys33-thr1 crosslinking at subunit beta5 of the yeast 20s proteasome |
|
64
|
231
|
4qz3E |
Ycp beta5-a49v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
222
|
4qwlH |
Ycp beta5-a50v mutant in complex with carfilzomib |
|
61
|
231
|
4qvpE |
Ycp beta5-m45t mutant in complex with bortezomib |
|
67
|
233
|
4qv3M |
Ycp beta5-m45v mutant |
